National Health Act 1953 Amendment determinations under sections 85, 85A and 88 pharmaceutical benefits (No. PB 87 of 2008) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 87 of 2008
Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.
Dated 1st AUGUST 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — pharmaceutical benefits
1 Commencement
This instrument commences on 1 September 2008.
2 Amendment of PB 75 of 2008
Schedule 1 amends PB 75 of 2008.
Schedule 1 Amendments
[1] Part 1 of Schedule 1, item dealing with Alendronic acid in the form
Tablet 70 mg (as alendronate sodium)
in the column headed “Brand” insert in alphabetical order:
Alendronate Sandoz
[2] Part 1 of Schedule 1, item dealing with Alendronic acid with colecalciferol in the form
Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol
omit from the column headed “Brand”:
Fosamax Plus 70mg/140ug
and substitute:
Fosamax Plus 70mg/140mcg
[3] Part 1 of Schedule 1, item dealing with Bicalutamide
in the column headed “Brand” insert in alphabetical order:
Bicalutamide Ranbaxy
[4] Part 1 of Schedule 1, item dealing with Cephalexin in the form Capsule 250 mg (anhydrous)
in the column headed “Brand” insert in alphabetical order:
Cephatrust 250
[5] Part 1 of Schedule 1, item dealing with Cephalexin in the form Capsule 500 mg (anhydrous)
in the column headed “Brand” insert in alphabetical order:
Cephatrust 500
[6] Part 1 of Schedule 1, after item dealing with Clarithromycin in the form Tablet 250 g
insert in the columns in the order indicated:
| Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral | 1 | . . | Klacid |
[7] Part 1 of Schedule 1, item dealing with Diazepam in the form Tablet 2 mg
omit from the column headed “Brand”:
Ranzepam
[8] Part 1 of Schedule 1, omit item dealing with Dipivefrine
[9] Part 1 of Schedule 1, item dealing with Electrolyte Replacement, Oral
(a) omit from the column headed “Brand”:
Chem mart Oral Rehydration Salts
(b) omit from the column headed “Brand”:
Terry White Chemists Oral Rehydration Salts
[10] Part 1 of Schedule 1, items dealing with Glucose Indicator—Blood
insert as first entry in the columns in the order indicated:
| Electrode strips, 25 (On-Call Plus) | For external use | 4 | 5 | On-Call Plus |
[11] Part 1 of Schedule 1, item dealing with Lisinopril in the form Tablet 5 mg
in the column headed “Brand” insert in alphabetical order:
Lisinotrust 5
[12] Part 1 of Schedule 1, item dealing with Lisinopril in the form Tablet 10 mg
in the column headed “Brand” insert in alphabetical order:
Lisinotrust 10
[13] Part 1 of Schedule 1, item dealing with Lisinopril in the form Tablet 20 mg
in the column headed “Brand” insert in alphabetical order:
Lisinotrust 20
[14] Part 1 of Schedule 1, item dealing with Metformin in the forms Tablet containing metformin hydrochloride 500 mg and Tablet containing metformin hydrochloride 850 mg
in the column headed “Brand” insert in alphabetical order:
Metformin generichealth
[15] Part 1 of Schedule 1, item dealing with Omeprazole in the form Tablet 20 mg
in the column headed “Brand” insert in alphabetical order:
Omeprazole Ranbaxy
[16] Part 1 of Schedule 1, item dealing with Paracetamol in the form Tablet 500 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacy Choice Paracetamol
[17] Part 1 of Schedule 1, item dealing with Quinapril in the form Tablet 5 mg (as hydrochloride)
in the column headed “Brand” insert in alphabetical order:
Quinapril Sandoz
[18] Part 1 of Schedule 1, item dealing with Ramipril in the form Capsule 1.25 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacor Ramipril 1.25
[19] Part 1 of Schedule 1, item dealing with Ramipril in the form Capsule 2.5 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacor Ramipril 2.5
[20] Part 1 of Schedule 1, item dealing with Ramipril in the form Capsule 5 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacor Ramipril 5
[21] Part 1 of Schedule 1, item dealing with Ramipril in the form Tablet 10 mg
in the column headed “Brand” insert in alphabetical order:
Ramipril Sandoz
[22] Part 1 of Schedule 1, item dealing with Ramipril in the form Capsule 10 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacor Ramipril 10
[23] Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 50 mg (as hydrochloride)
in the column headed “Brand” insert in alphabetical order:
Sertratrust 50
[24] Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 100 mg (as hydrochloride)
in the column headed “Brand” insert in alphabetical order:
Sertratrust 100
[25] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg
in the column headed “Brand” insert in alphabetical order:
Simvatrust 10
[26] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg
in the column headed “Brand” insert in alphabetical order:
Simvatrust 20
[27] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg
in the column headed “Brand” insert in alphabetical order:
Simvatrust 40
[28] Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg
in the column headed “Brand” insert in alphabetical order:
Simvatrust 80
[29] Part 1 of Schedule 1, item dealing with Tramadol in the form Injection containing tramadol hydrochloride
100 mg in 2 mL
omit from the column headed “Brand”:
Tramahexal
[30] Part 1 of Schedule 1, item dealing with Trandolapril in the forms Capsule 500 micrograms, Capsule 1 mg,
Capsule 2 mg and Capsule 4 mg
(a) in the column headed “Brand” insert in alphabetical order:
APO-Trandolapril
(b) in the column headed “Brand” insert in alphabetical order:
Trandolapril-DP
[31] Part 2 of Schedule 1
omit from the column headed “Listed Drug”:
Chrionic Gonadotrophin
and substitute:
Chorionic Gonadotrophin
[32] Part 2 of Schedule 1, item dealing with Diazepam in the form Tablet 2 mg
omit from the column headed “Brand”:
Ranzepam
[33] Part 2 of Schedule 1, item dealing with Omeprazole in the form Tablet 20 mg
in the column headed “Brand” insert in alphabetical order:
Omeprazole Ranbaxy
[34] Part 2 of Schedule 1, item dealing with Paracetamol
in the column headed “Brand” insert in alphabetical order:
Pharmacy Choice Paracetamol
[35] Part 1 of Schedule 2, item dealing with Diazepam in the form Tablet 2 mg
omit from the column headed “Brand”:
Ranzepam
[36] Part 2 of Schedule 2, item dealing with Diazepam in the form Tablet 2 mg
omit from the column headed “Brand”:
Ranzepam
[37] Part 1 of Schedule 3, item dealing with Cephalexin in the form Capsule 250 mg (anhydrous)
in the column headed “Brand” insert in alphabetical order:
Cephatrust 250
[38] Part 1 of Schedule 3, item dealing with Cephalexin in the form Capsule 500 mg (anhydrous)
in the column headed “Brand” insert in alphabetical order:
Cephatrust 500
[39] Part 1 of Schedule 3, item dealing with Diazepam in the form Tablet 2 mg
omit from the column headed “Brand”:
Ranzepam
[40] Part 1 of Schedule 3, item dealing with Paracetamol in the form Tablet 500 mg
in the column headed “Brand” insert in alphabetical order:
Pharmacy Choice Paracetamol
[41] Part 1 of Schedule 3, item dealing with Tramadol in the form Injection containing tramadol hydrochloride 100 mg in 2 mL
omit from the column headed “Brand”:
Tramahexal
[42] Part 2 of Schedule 3, item dealing with Paracetamol
in the column headed “Brand” insert in alphabetical order:
Pharmacy Choice Paracetamol
0
0
0